AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
CISPLATIN-INDUCED NONCONVULSIVE ENCEPHALOPATHY
Authors: LYASS O LOSSOS A HUBERT A GIPS M PERETZ T
Citation: O. Lyass et al., CISPLATIN-INDUCED NONCONVULSIVE ENCEPHALOPATHY, Anti-cancer drugs, 9(1), 1998, pp. 100-104
A PHASE-II TRIAL OF CPT-11 IN PATIENTS (PTS) WITH ADVANCED GASTRIC-CARCINOMA (AGC)
Authors: KOHNE C THUSSPATIENCE P CATANE R",KLEIN,"PERETZ T DUCREUX NM WILKE H JACQUES C
Citation: C. Kohne et al., A PHASE-II TRIAL OF CPT-11 IN PATIENTS (PTS) WITH ADVANCED GASTRIC-CARCINOMA (AGC), Annals of oncology, 9, 1998, pp. 219-219
CENTRAL-NERVOUS-SYSTEM (CNS) RELAPSE IN BREAST-CANCER PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION(ASCT)
Authors: NAGLER A LOSSOS A BOKSTEIN F PERETZ T SIEGAL T
Citation: A. Nagler et al., CENTRAL-NERVOUS-SYSTEM (CNS) RELAPSE IN BREAST-CANCER PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION(ASCT), Neurology, 50(4), 1998, pp. 16002-16002
EVALUATION OF TISSUE POLYPEPTIDE SPECIFIC ANTIGEN, CYFRA-21-1, AND CARCINOEMBRYONIC ANTIGEN IN NONSMALL CELL LUNG-CARCINOMA - DOES THE COMBINED USE OF CYTOKERATIN MARKERS GIVE ANY ADDITIONAL INFORMATION
Authors: NISMAN B LAFAIR J HECHING N LYASS O BARAS M PERETZ T BARAK V
Citation: B. Nisman et al., EVALUATION OF TISSUE POLYPEPTIDE SPECIFIC ANTIGEN, CYFRA-21-1, AND CARCINOEMBRYONIC ANTIGEN IN NONSMALL CELL LUNG-CARCINOMA - DOES THE COMBINED USE OF CYTOKERATIN MARKERS GIVE ANY ADDITIONAL INFORMATION, Cancer, 82(10), 1998, pp. 1850-1859
DOUBLE HETEROZYGOTES FOR THE ASHKENAZI FOUNDER MUTATIONS IN BRCA1 ANDBRCA2 GENES
Authors: FRIEDMAN E BRUCHIM RB KRUGLIKOVA A RISEL S LEVYLAHAD E HALLE D BARON E GERSHONIBARUCH R DAGAN E KEPTEN I PERETZ T LERER I WIENBERG N SHUSHAN A ABELIOVICH D
Citation: E. Friedman et al., DOUBLE HETEROZYGOTES FOR THE ASHKENAZI FOUNDER MUTATIONS IN BRCA1 ANDBRCA2 GENES, American journal of human genetics, 63(4), 1998, pp. 1224-1227
THE 8765DELAG MUTATION IN BRCA2 IS COMMON AMONG JEWS OF YEMENITE EXTRACTION
Authors: LERER I WANG TL PERETZ T SAGI M KADURI L ORRURTREGER A STADLER J GUTMAN H ABELIOVICH D
Citation: I. Lerer et al., THE 8765DELAG MUTATION IN BRCA2 IS COMMON AMONG JEWS OF YEMENITE EXTRACTION, American journal of human genetics, 63(1), 1998, pp. 272-274
COMBINATION OF INTERFERON AND TAMOXIFEN FOR PATIENTS WITH ADVANCED BREAST-CANCER AND NEGATIVE ESTROGEN-RECEPTORS
Authors: PERETZ T KAPLANDENOUR A BAIDER L HUBERT A STEPHANOS S BARAK V
Citation: T. Peretz et al., COMBINATION OF INTERFERON AND TAMOXIFEN FOR PATIENTS WITH ADVANCED BREAST-CANCER AND NEGATIVE ESTROGEN-RECEPTORS, Breast, 6(4), 1997, pp. 190-193
TPS IN ASSESSING RESPONSE TO THERAPY AND PROGNOSIS OF BREAST-CANCER PATIENTS TREATED WITH INTERFERONS
Authors: BARAK V NISMAN B ROISMAN I HUBERT A FARBSTEIN H BAIDER L KAPLAN A HALPERIN T STEPHANOS S PERETZ T
Citation: V. Barak et al., TPS IN ASSESSING RESPONSE TO THERAPY AND PROGNOSIS OF BREAST-CANCER PATIENTS TREATED WITH INTERFERONS, Journal of tumor marker oncology, 12(4), 1997, pp. 17-25
MULTIPLE PARENCHYMAL LIVER METASTASES AS THE FIRST SITE OF RECURRENT OVARIAN-CARCINOMA - A CASE-REPORT AND REVIEW OF THE LITERATURE
Authors: LYASS O BRUFMAN G EDELMANN DZ PRUS D LEBENSART PD PERETZ T
Citation: O. Lyass et al., MULTIPLE PARENCHYMAL LIVER METASTASES AS THE FIRST SITE OF RECURRENT OVARIAN-CARCINOMA - A CASE-REPORT AND REVIEW OF THE LITERATURE, European journal of gynaecological oncology, 18(1), 1997, pp. 68-70
INACTIVATION OF A VOLTAGE-DEPENDENT K-SUBUNIT - MODULATION BY A PHOSPHORYLATION-DEPENDENT INTERACTION BETWEEN THE DISTAL C-TERMINUS OF A SUBUNIT AND CYTOSKELETON( CHANNEL BY BETA)
Authors: JING J PERETZ T SINGERLAHAT D CHIKVASHVILI D THORNHILL WB LOTAN I
Citation: J. Jing et al., INACTIVATION OF A VOLTAGE-DEPENDENT K-SUBUNIT - MODULATION BY A PHOSPHORYLATION-DEPENDENT INTERACTION BETWEEN THE DISTAL C-TERMINUS OF A SUBUNIT AND CYTOSKELETON( CHANNEL BY BETA), Neuroscience letters, 1997, pp. 26-26
INTERLEUKIN-6 SECRETION IN MICE IS ASSOCIATED WITH REDUCED GLUCOSE-6-PHOSPHATASE AND LIVER-GLYCOGEN LEVELS
Authors: METZGER S GOLDSCHMIDT N BARASH V PERETZ T DRIZE O SHILYANSKY J SHILONI E CHAJEKSHAUL T
Citation: S. Metzger et al., INTERLEUKIN-6 SECRETION IN MICE IS ASSOCIATED WITH REDUCED GLUCOSE-6-PHOSPHATASE AND LIVER-GLYCOGEN LEVELS, American journal of physiology: endocrinology and metabolism, 36(2), 1997, pp. 262-267
BRCA1 MUTATIONS IN WOMEN WITH OVARIAN-CANCER
Authors: SHUSHAN A ABELIOVICH D PERETZ T WEINBERG N PALTIEL O
Citation: A. Shushan et al., BRCA1 MUTATIONS IN WOMEN WITH OVARIAN-CANCER, JAMA, the journal of the American Medical Association, 277(12), 1997, pp. 963-963
THE EFFECT OF BEHAVIORAL INTERVENTION ON THE PSYCHOLOGICAL DISTRESS OF HOLOCAUST SURVIVORS WITH CANCER
Authors: BAIDER L PERETZ T DENOUR AK
Citation: L. Baider et al., THE EFFECT OF BEHAVIORAL INTERVENTION ON THE PSYCHOLOGICAL DISTRESS OF HOLOCAUST SURVIVORS WITH CANCER, Psychotherapy and psychosomatics, 66(1), 1997, pp. 44-49
TUMOR-NECROSIS-FACTOR INHIBITS THE TRANSCRIPTIONAL RATE OF GLUCOSE-6-PHOSPHATASE IN-VIVO AND IN-VITRO
Authors: METZGER S BEGLEIBTER N BARASH V DRIZE O PERETZ T SHILONI E CHAJEKSHAUL T
Citation: S. Metzger et al., TUMOR-NECROSIS-FACTOR INHIBITS THE TRANSCRIPTIONAL RATE OF GLUCOSE-6-PHOSPHATASE IN-VIVO AND IN-VITRO, Metabolism, clinical and experimental, 46(5), 1997, pp. 579-583
INACTIVATION OF A VOLTAGE-DEPENDENT K-SUBUNIT - MODULATION BY A PHOSPHORYLATION-DEPENDENT INTERACTION BETWEEN THE DISTAL C-TERMINUS OF ALPHA-SUBUNIT AND CYTOSKELETON( CHANNEL BY BETA)
Authors: JING J PERETZ T SINGERLAHAT D CHIKVASHVILI D THORNHILL WB LOTAN I
Citation: J. Jing et al., INACTIVATION OF A VOLTAGE-DEPENDENT K-SUBUNIT - MODULATION BY A PHOSPHORYLATION-DEPENDENT INTERACTION BETWEEN THE DISTAL C-TERMINUS OF ALPHA-SUBUNIT AND CYTOSKELETON( CHANNEL BY BETA), The Journal of biological chemistry, 272(22), 1997, pp. 14021-14024
DIRECTLY DERIVED PENETRANCE ESTIMATES FOR THE FOUNDER BRCA1 BRCA2 MUTATIONS IN JEWS - THE ISRAELI CONSORTIUM ON HEREDITARY BREAST-CANCER/
Authors: LEVYLAHAD E GERSHONIBARUCH R SAGI M ORRURTREGER A BENYEHUDA A DAGAN E BARSADE R LAHAD A HALLE D PERETZ T FRIEDMAN E
Citation: E. Levylahad et al., DIRECTLY DERIVED PENETRANCE ESTIMATES FOR THE FOUNDER BRCA1 BRCA2 MUTATIONS IN JEWS - THE ISRAELI CONSORTIUM ON HEREDITARY BREAST-CANCER/, American journal of human genetics, 61(4), 1997, pp. 389-389
THE FOUNDER MUTATIONS 185DELAG AND 5382INSC IN BRCA1 AND 6174DELT IN BRCA2 APPEAR IN 60-PERCENT OF OVARIAN-CANCER AND 30-PERCENT OF EARLY-ONSET BREAST-CANCER PATIENTS AMONG ASHKENAZI WOMEN
Authors: ABELIOVICH D KADURI L LERER I WEINBERG N AMIR G SAGI M ZLOTOGORA J HECHING N PERETZ T
Citation: D. Abeliovich et al., THE FOUNDER MUTATIONS 185DELAG AND 5382INSC IN BRCA1 AND 6174DELT IN BRCA2 APPEAR IN 60-PERCENT OF OVARIAN-CANCER AND 30-PERCENT OF EARLY-ONSET BREAST-CANCER PATIENTS AMONG ASHKENAZI WOMEN, American journal of human genetics, 60(3), 1997, pp. 505-514
THE CARRIER FREQUENCY OF THE BRCA1 185DELAG MUTATION IS APPROXIMATELY1 PERCENT IN ASHKENAZI JEWISH INDIVIDUALS (VOL 11, PG 198, 1995)
Authors: STRUEWING JP ABELIOVICH D PERETZ T AVISHAI N KABACK MM COLLINS FS BRODY LC
Citation: Jp. Struewing et al., THE CARRIER FREQUENCY OF THE BRCA1 185DELAG MUTATION IS APPROXIMATELY1 PERCENT IN ASHKENAZI JEWISH INDIVIDUALS (VOL 11, PG 198, 1995), Nature genetics, 12(1), 1996, pp. 110-110
HEPATIC ARTERIAL BOLUS CHEMOTHERAPY FOR COLORECTAL METASTASES USING AN IMPLANTABLE PORT - A NEGATIVE INFLUENCE OF PREVIOUS SYSTEMIC TREATMENT
Authors: LYASS S LYASS O GABIZON A PERETZ T EID A MUGGIASULLAM M DURST AL SHILONI E
Citation: S. Lyass et al., HEPATIC ARTERIAL BOLUS CHEMOTHERAPY FOR COLORECTAL METASTASES USING AN IMPLANTABLE PORT - A NEGATIVE INFLUENCE OF PREVIOUS SYSTEMIC TREATMENT, International journal of oncology, 9(6), 1996, pp. 1295-1299
TREATMENT RESPONSE IN METASTATIC BREAST-CANCER - A MULTICENTER STUDY COMPARING UICC CRITERIA AND TUMOR-MARKER CHANGES
Authors: VANDALEN A HEERING KJ BARAK V PERETZ T CREMASCHI A GERONI P GION M SARACCHINI S MOLINA R NAMER M STIEBER P STURGEON C LEONARD RCF EINARSSON R
Citation: A. Vandalen et al., TREATMENT RESPONSE IN METASTATIC BREAST-CANCER - A MULTICENTER STUDY COMPARING UICC CRITERIA AND TUMOR-MARKER CHANGES, Breast, 5(2), 1996, pp. 82-88
DELETION OF THE N-TERMINUS OF A K-TERM MODULATION BY CAMP AND BETA-1-ADRENERGIC RECEPTOR ACTIVATION( CHANNEL BRINGS ABOUT SHORT)
Authors: LEVIN G PERETZ T CHIKVASHVILLI D JING J LOTAN I
Citation: G. Levin et al., DELETION OF THE N-TERMINUS OF A K-TERM MODULATION BY CAMP AND BETA-1-ADRENERGIC RECEPTOR ACTIVATION( CHANNEL BRINGS ABOUT SHORT), Journal of molecular neuroscience, 7(4), 1996, pp. 269-276
BREAST-CANCER - SCREENING, DETECTION, TUMOR-MARKERS AND SURGICAL-MANAGEMENT
Authors: ROISMAN I BARAK V REZNICK A BITTERMAN A PERETZ T DURST AL
Citation: I. Roisman et al., BREAST-CANCER - SCREENING, DETECTION, TUMOR-MARKERS AND SURGICAL-MANAGEMENT, Journal of tumor marker oncology, 11(2), 1996, pp. 131-155
SULFATE MOIETIES IN THE SUBENDOTHELIAL EXTRACELLULAR-MATRIX ARE INVOLVED IN BASIC FIBROBLAST GROWTH-FACTOR SEQUESTRATION, DIMERIZATION, ANDSTIMULATION OF CELL-PROLIFERATION
Authors: MIAO HQ ISHAIMICHAELI R ATZMON R PERETZ T VLODAVSKY I
Citation: Hq. Miao et al., SULFATE MOIETIES IN THE SUBENDOTHELIAL EXTRACELLULAR-MATRIX ARE INVOLVED IN BASIC FIBROBLAST GROWTH-FACTOR SEQUESTRATION, DIMERIZATION, ANDSTIMULATION OF CELL-PROLIFERATION, The Journal of biological chemistry, 271(9), 1996, pp. 4879-4886
PHOSPHORYLATION OF A K-SUBUNIT MODULATES THE INACTIVATION CONFERRED BY A BETA-SUBUNIT - INVOLVEMENT OF CYTOSKELETON( CHANNEL ALPHA)
Authors: LEVIN G CHIKVASHVILI D SINGERLAHAT D PERETZ T THORNHILL WB LOTAN I
Citation: G. Levin et al., PHOSPHORYLATION OF A K-SUBUNIT MODULATES THE INACTIVATION CONFERRED BY A BETA-SUBUNIT - INVOLVEMENT OF CYTOSKELETON( CHANNEL ALPHA), The Journal of biological chemistry, 271(46), 1996, pp. 29321-29328
THERAPEUTIC APPROACH TO OVARIAN CYSTS IN TAMOXIFEN-TREATED WOMEN WITHBREAST-CANCER
Authors: SHUSHAN A PERETZ T MORYOSEF S
Citation: A. Shushan et al., THERAPEUTIC APPROACH TO OVARIAN CYSTS IN TAMOXIFEN-TREATED WOMEN WITHBREAST-CANCER, International journal of gynaecology and obstetrics, 52(3), 1996, pp. 249-253
Risultati: 1-25 | 26-50